Pacific Research Institute

NEW ISSUE BRIEF: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs By 17 Percent

March 09, 2020

Healthcare

Expanding the use of biosimilars to treat serious illnesses like cancer or auto-immune diseases could reduce a patient’s out-of-pocket costs by 17 percent, finds a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute. Click here to...

CAPITAL IDEAS: Will California’s Ban on Freelance Work Lead to Blue State Turnaround?

February 10, 2020

The backlash over California’s Assembly Bill 5, legislation that robs workers of their freedom, was likely not expected by lawmakers. They’re accustomed to an electorate that agreeably goes along with whatever policies they impose, no matter how invasive. The response to AB5, which outlaws, with a...

PRI Single-Payer Poll Watch

January 16, 2020

Healthcare

Health care continues to be one of the most contentious public policy issues in the United States. Close to a decade after the passage of the Affordable Care Act, public sentiment continues to evolve: more government control or less? To inform the public on the...

NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs

January 08, 2020

Healthcare

As Washington pushes for price caps and government controls to address prescription drug prices, a new issue brief released today by the Center for Medical Economics and Innovation at the Pacific Research Institute argues that reforming the complex drug supply chain and ending the current...

Studies

NEW ISSUE BRIEF: Expanding Biosimilars Use Could Save Patients, Reduce Out-of-Pocket Costs By 17 Percent

CAPITAL IDEAS: Will California’s Ban on Freelance Work Lead to Blue State Turnaround?

PRI Single-Payer Poll Watch

NEW STUDY shows that Reforming Supply Chain & Drug Pricing System Will Lower Health Care Costs

ABOUT PRI

RESEARCH AREAS

OUR WORK

Gallery